Active-duty US soldiers to receive psychedelic drugs for PTSD next year
Hope that multiple sessions of MDMA-assisted therapy could help soldiers fight longer by helping them process trauma
Opening excerpt (first ~120 words) tap to expand
Composite: Rita Liu/The Guardian/Getty Images/UnsplashView image in fullscreen Composite: Rita Liu/The Guardian/Getty Images/UnsplashUS militaryActive-duty US soldiers to receive psychedelic drugs for PTSD next yearHope that sessions of MDMA-assisted therapy could help soldiers fight longer by helping them process traumaMattha BusbyThu 30 Apr 2026 11.00 EDTLast modified on Thu 30 Apr 2026 11.01 EDTSharePrefer the Guardian on GoogleAs the war on drugs approaches its end, a new doctrine could soon take hold: psychedelic drugs for active-duty soldiers suffering from PTSD.In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.The deputy under secretary of war for personnel and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — World.
Discussion
0 commentsMore from The Guardian — World
